The Discounted Cash Flow (DCF) valuation of CureVac NV (CVAC) is (1.03) USD. With the latest stock price at 4.66 USD, the upside of CureVac NV based on DCF is -122.2%.
Based on the latest price of 4.66 USD and our DCF valuation, CureVac NV (CVAC) is a sell. selling CVAC stocks now will result in a potential gain of 122.2%.
Note: valuation result may not be accurate due to the company's negative cashflows.
| Range | Selected | |
| WACC / Discount Rate | 6.5% - 8.6% | 7.6% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (5.01) - 0.06 | (1.03) |
| Upside | -207.6% - -98.7% | -122.2% |